Sign In
Buy HCAT
$1.33
-0.0200 (-1.48%)
At Close: Jun 03, 2026
Health Catalyst to Participate in Upcoming Investor Conferences
04:05pm, Thursday, 30'th May 2024
SALT LAKE CITY, May 30, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,
3 Medical Info Systems Stocks to Buy as GenAI Transforms Healthcare
12:26pm, Tuesday, 28'th May 2024
Zacks Medical Info Systems industry stocks like Hims & Hers Health (HIMS), Enovis Corporation (ENOV) and Health Catalyst (HCAT) are expected to gain from the GenAI wave.
Why Health Catalyst (HCAT) Might be Well Poised for a Surge
01:21pm, Monday, 27'th May 2024
Health Catalyst (HCAT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts See a 75.19% Upside in Health Catalyst (HCAT): Can the Stock Really Move This High?
11:00am, Monday, 27'th May 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 75.2% in Health Catalyst (HCAT). While the effectiveness of this highly sought-after metric is questionable, th
Health Catalyst Unveils Next-Generation Data and Analytics Ecosystem Built for Healthcare, Health Catalyst Ignite®
09:00am, Tuesday, 21'st May 2024
SALT LAKE CITY , May 21, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, tod
Should You Invest in the Vanguard Health Care ETF?
01:18pm, Monday, 20'th May 2024
Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the An increasingly popular option among retail and institutional investors, passively managed ET
Peeling Back The Layers: Exploring Bruker Through Analyst Insights
10:00am, Monday, 20'th May 2024
Throughout the last three months, 4 analysts have evaluated Bruker BRKR, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the table below illustrates t
Health Catalyst, Inc. (HCAT) Q1 2024 Earnings Call Transcript
10:50pm, Thursday, 09'th May 2024
Health Catalyst, Inc. (NASDAQ:HCAT ) Q1 2024 Earnings Conference Call May 9, 2024 5:00 PM ET Company Participants Jack Knight - VP, Investor Relations Daniel Burton - CEO & Director Jason Alger - CFO
Health Catalyst (HCAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
07:31pm, Thursday, 09'th May 2024
The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street
Health Catalyst (HCAT) Q1 Earnings Beat Estimates
06:51pm, Thursday, 09'th May 2024
Health Catalyst (HCAT) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.05 per share a year ago.
Health Catalyst Reports First Quarter 2024 Results
04:03pm, Thursday, 09'th May 2024
SALT LAKE CITY, May 09, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,
Health Catalyst (HCAT) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:17am, Wednesday, 08'th May 2024
Get a deeper insight into the potential performance of Health Catalyst (HCAT) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates
Health Catalyst to Announce First Quarter 2024 Operating Results and Host Conference Call on Thursday, May 9, 2024
08:00am, Wednesday, 24'th Apr 2024
SALT LAKE CITY, April 24, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations
Down -24.71% in 4 Weeks, Here's Why You Should You Buy the Dip in Health Catalyst (HCAT)
10:35am, Monday, 08'th Apr 2024
Health Catalyst (HCAT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings est
Wall Street Analysts Think Health Catalyst (HCAT) Could Surge 53.65%: Read This Before Placing a Bet
10:56am, Monday, 25'th Mar 2024
The mean of analysts' price targets for Health Catalyst (HCAT) points to a 53.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among
